Chronic disease and recent addiction treatment utilization among alcohol and drug dependent adults

Substance Abuse: Treatment, Prevention, and Policy

Volumn 6, Issue 1, 2011, Pages

  Reif, Sharon ^a   Larson, Mary Jo ^a   Cheng, Debbie M ^b   Allensworth Davies, Donald ^b   Samet, Jeffrey ^b,c,d   Saitz, Richard ^b,c,d  

^a BRANDEIS UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON MEDICAL CENTER   (United States)

Author keywords

Addiction; Chronic disease; Medical care; Substance abuse; Treatment

Indexed keywords

ADDICTION; ADOLESCENT; ADULT; AGED; ALCOHOLISM; ARTICLE; CHRONIC DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDY; FEMALE; HEALTH STATUS; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; PATIENT ATTITUDE; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF REPORT; STATISTICS;

ADOLESCENT; ADULT; AGED; ALCOHOLISM; CHRONIC DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELF REPORT; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS;

EID: 80054090785     PISSN: None     EISSN: 1747597X     Source Type: Journal    
DOI: 10.1186/1747-597X-6-28     Document Type: Article

References (51)

1. National Health Expenditure Data, Historical. , http://www.cms.hhs.gov/NationalHealthExpendData/02_NationalHealthAccountsHistorical.asp#TopOfPage
2. Chronic Disease Overview. , http://www.cdc.gov/NCCdphp/overview.htm
3. Clark RE, Samnaliev M, McGovern MP. Impact of substance disorders on medical expenditures for medicaid beneficiaries with behavioral health disorders. Psychiatr Serv 2009, 60:35-42. 10.1176/appi.ps.60.1.35, 19114568.
4. Mark TL, Levit KR, Coffey RM, McKusick DR, Harwood HJ, King EC, Bouchery E, Genuardi JS, Vandivort-Warren R, Buck JA, Ryan K. National Expenditures for Mental Health Services and Substance Abuse Treatment, 1993-2003. 2007, Rockville, MD: Substance Abuse and Mental Health Services Administration.
5. Office of National Drug Control Policy The Economic Costs of Drug Abuse in the United States, 1992-2002. 2004, Washington, D.C.: Executive Office of the President, Office of National Drug Control Policy.
6. Substance Abuse and Mental Health Services Administration Results from the 2008 National Survey on Drug Use and Health: National Findings. 2009, Rockville, MD: Office of Applied Studies, Substance Abuse and Mental Health Services Administration.
7. Paez KA, Zhao L, Hwang W. Rising out-of-pocket spending for chronic conditions: a ten-year trend. Health Aff (Millwood) 2009, 28:15-25.
8. Decker SL, Schappert SM, Sisk JE. Use of medical care for chronic conditions. Health Aff (Millwood) 2009, 28:26-35.
9. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med 1998, 338:1516-1520. 10.1056/NEJM199805213382106, 9593791.
10. Borowsky SJ, Rubenstein LV, Meredith LS, Camp P, Jackson-Triche M, Wells KB. Who is at risk of nondetection of mental health problems in primary care?. J Gen Intern Med 2000, 15:381-388. 10.1046/j.1525-1497.2000.12088.x, 1495467, 10886472.
11. Saitz R, Mulvey KP, Plough A, Samet JH. Physician unawareness of serious substance abuse. Am J Drug Alcohol Abuse 1997, 23:343-354. 10.3109/00952999709016881, 9261484.
12. Graham AW, Schultz TK, Mayo-Smith MF, Ries RK, Wilford BB. Principles of Addiction Medicine 2003, Chevy Chase, MD: American Society of Addiction Medicine, 3.
13. Institute of Medicine Improving the Quality of Health Care for Mental and Substance-Use Conditions 2006, Washington, D.C.: National Academies Press, Institute of Medicine.
14. Banerjea R, Sambamoorthi U, Smelson D, Pogach LM. Expenditures in mental illness and substance use disorders among veteran clinic users with diabetes. J Behav Health Serv Res 2008, 35:290-303. 10.1007/s11414-008-9120-8, 18512155.
15. Garnick DW, Hendricks AM, Comstock C, Horgan C. Do individuals with substance abuse diagnoses incur higher charges than individuals with other chronic conditions?. J Subst Abuse Treat 1997, 14:457-465. 10.1016/S0740-5472(97)00137-2, 9437615.
16. Thomas MR, Waxmonsky JA, Gabow PA, Flanders-McGinnis G, Socherman R, Rost K. Prevalence of psychiatric disorders and costs of care among adult enrollees in a Medicaid HMO. Psychiatr Serv 2005, 56:1394-1401. 10.1176/appi.ps.56.11.1394, 16282258.
17. Wadland WC, Ferenchick GS. Medical comorbidity in addictive disorders. Psychiatr Clin North Am 2004, 27:675-687. 10.1016/j.psc.2004.06.006, 15550287.
18. Mertens JR, Lu YW, Parthasarathy S, Moore C, Weisner CM. Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison with matched controls. Arch Intern Med 2003, 163:2511-2517. 10.1001/archinte.163.20.2511, 14609789.
19. Larson MJ, Paasche-Orlow M, Cheng DM, Lloyd-Travaglini C, Saitz R, Samet JH. Persistent pain is associated with substance use after detoxification: a prospective cohort analysis. Addiction 2007, 102:752-760. 10.1111/j.1360-0443.2007.01759.x, 17506152.
20. Dickey B, Normand SL, Weiss RD, Drake RE, Azeni H. Medical morbidity, mental illness, and substance use disorders. Psychiatr Serv 2002, 53:861-867. 10.1176/appi.ps.53.7.861, 12096170.
21. Fox K, Merrill JC, Chang HH, Califano JA. Estimating the costs of substance abuse to the Medicaid hospital care program. Am J Public Health 1995, 85:48-54. 10.2105/AJPH.85.1.48, 1615270, 7832261.
22. De Alba I, Samet JH, Saitz R. Burden of medical illness in drug- and alcohol-dependent persons without primary care. Am J Addict 2004, 13:33-45. 10.1080/10550490490265307, 14766436.
23. Mee-Lee D, Shulman GD, Fishman M, Gastfriend DR, Griffith JH, . (Eds.) ASAM Patient Placement Criteria for the Treatment of Substance-Related Disorders, 2nd edition-revised 2001, Chevy Chase, MD: American Society of Addiction Medicine, (Eds.).
24. Schulz JE. The integration of medical management with recovery. J Psychoactive Drugs 1997, 29:233-237. 10.1080/02791072.1997.10400196, 9339854.
25. Ford JD, Trestman RL, Steinberg K, Tennen H, Allen S. Prospective association of anxiety, depressive, and addictive disorders with high utilization of primary, specialty and emergency medical care. Soc Sci Med 2004, 58:2145-2148. 10.1016/j.socscimed.2003.08.017, 15047073.
26. Ford JD, Trestman RL, Tennen H, Allen S. Relationship of anxiety, depression and alcohol use disorders to persistent high utilization and potentially problematic under-utilization of primary medical care. Soc Sci Med 2005, 61:1618-1625. 10.1016/j.socscimed.2005.03.017, 16005791.
27. Banerjea R, Sambamoorthi U, Smelson D, Pogach LM. Chronic illness with complexities: mental illness and substance use among Veteran clinic users with diabetes. Am J Drug Alcohol Abuse 2007, 33:807-821. 10.1080/00952990701653701, 17994477.
28. Merrick EL, Horgan CM, Garnick DW, Hodgkin D, Morley M. Health plans' disease management programs: extending across the medical and behavioral health spectrum?. J Ambul Care Manage 2008, 31:342-353.
29. Saitz R, Larson MJ, LaBelle C, Richardson J, Samet JH. The case for chronic disease management for addiction. J Addict Med 2008, 2:55-65. 10.1097/ADM.0b013e318166af74, 2756688, 19809579.
30. Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q 1996, 74:511-544. 10.2307/3350391, 8941260.
31. Kessler RC, Andrews G, Mroczek D, Ustun B, Wittchen HU. The World Health Organization Composite International Diagnostic Interview short-form (CIDI-SF). Int J Methods Psychiatr Res 1998, 7:171-185.
32. Smith KL, Horton NJ, Saitz R, Samet JH. The use of the mini-mental state examination in recruitment for substance abuse research studies. Drug Alcohol Depend 2006, 82:231-237. 10.1016/j.drugalcdep.2005.09.012, 16256278.
33. Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be measured by questionnaire rather than medical record review?. Med Care 1996, 34:73-84. 10.1097/00005650-199601000-00006, 8551813.
34. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383. 10.1016/0021-9681(87)90171-8, 3558716.
35. Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996, 34:220-233. 10.1097/00005650-199603000-00003, 8628042.
36. Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 2006, 295:2003-2017. 10.1001/jama.295.17.2003, 16670409.
37. Beebe TJ, McRae JA, Barnes SA. A comparison of self-reported use of behavioral health services with Medicaid agency records in Minnesota. Psychiatr Serv 2006, 57:1652-1654. 10.1176/appi.ps.57.11.1652, 17085617.
38. Killeen TK, Brady KT, Gold PB, Tyson C, Simpson KN. Comparison of self-report versus agency records of service utilization in a community sample of individuals with alcohol use disorders. Drug Alcohol Depend 2004, 73:141-147. 10.1016/j.drugalcdep.2003.09.006, 14725953.
39. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988, 56:893-897.
40. McCullagh P, Nelder JA. Generalized Linear Models 1989, London: Chapman and Hall, 2.
41. Shanahan CW, Beers D, Alford DP, Brigandi E, Samet JH. A transitional opioid program to engage hospitalized drug users. J Gen Intern Med 2010, 25:803-808. 10.1007/s11606-010-1311-3, 2896583, 20237960.
42. Samet JH, Friedmann P, Saitz R. Benefits of linking primary medical care and substance abuse services: patient, provider, and societal perspectives. Arch Intern Med 2001, 161:85-91. 10.1001/archinte.161.1.85, 11146702.
43. Weisner C, Mertens J, Parthasarathy S, Moore C, Lu Y. Integrating primary medical care with addiction treatment: a randomized controlled trial. JAMA 2001, 286:1715-1723. 10.1001/jama.286.14.1715, 3056510, 11594896.
44. Weisner C, Ray GT, Mertens JR, Satre DD, Moore C. Short-term alcohol and drug treatment outcomes predict long-term outcome. Drug Alcohol Depend 2003, 71:281-294. 10.1016/S0376-8716(03)00167-4, 12957346.
45. National Center for Health Statistics Summary Health Statistics for U.S. Adults: National Health Interview Survey, 2008 (provisional report). Vital and Health Statistics, Series 10, Number 242 2009, Hyattsville, MD: Centers for Disease Control and Prevention, National Center for Health Statistics.
46. Massachusetts Department of Public Health A Profile of Health Among Massachusetts Adults, 2008: Results from the Behavioral Risk Factor Surveillance System. 2009, Boston, MA: Massachusetts Department of Public Health, Massachusetts Department of Public Health.
47. Gold DR, Wright R. Population disparities in asthma. Annu Rev Public Health 2005, 26:89-113. 10.1146/annurev.publhealth.26.021304.144528, 15760282.
48. Stein MD, Mulvey KP, Plough A, Samet JH. The functioning and well being of persons who seek treatment for drug and alcohol use. J Subst Abuse 1998, 10:75-84. 10.1016/S0899-3289(99)80142-4, 9720008.
49. Ilgen MA, Price AM, Burnett-Zeigler I, Perron B, Islam K, Bohnert AS, Zivin K. Longitudinal predictors of addictions treatment utilization in treatment-naive adults with alcohol use disorders. Drug Alcohol Depend 2011, 113:215-221. 10.1016/j.drugalcdep.2010.08.006, 20828944.
50. Larson MJ, Miller L, Becker M, Richardson E, Kammerer N, Thom J, Gampel J, Savage A. Physical health burdens of women with trauma histories and co-occurring substance abuse and mental disorders. J Behav Health Serv Res 2005, 32:128-140. 10.1007/BF02287262, 15834263.
51. Substance Abuse and Mental Health Services Administration Treatment Episode Data Set (TEDS) - Highlights 2007. National Admissions to Substance Abuse Treatment Services. 2009, Rockville, MD: Office of Applied Studies, Substance Abuse and Mental Health Services Administration.